Results 161 to 170 of about 45,372 (255)
A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosis. [PDF]
Park JS +22 more
europepmc +1 more source
The Six Pillars of Lifestyle Medicine in MASLD: An Evidence‐Based Guide
ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide and is projected to affect more than 40% of adults by 2050. Although pharmacologic therapies are emerging, lifestyle modification remains the foundation of management.
Jigyasa Sharma, Kathleen Viveiros
wiley +1 more source
The role of Kupffer cells in microbiota-brain communication: Sleep and fever signaling in response to lipopolysaccharide. [PDF]
Szentirmai É, Buckley K, Kapás L.
europepmc +1 more source
ABSTRACT Introduction The liver is essential for bacterial elimination, preventing intestinal bacteria from entering the systemic circulation, and for producing inflammatory cytokines. Glucocorticoids have been reported to exert heterogeneous effects on bacterial clearance in sepsis.
Katja Hanslin +6 more
wiley +1 more source
Inhibitor of differentiation 3 confers the robust anti-tumor activity of Kupffer cells. [PDF]
Ren J, Liu S, Zhang L.
europepmc +1 more source
Autophagy in MASLD: A Metabolic and Precision Medicine Perspective
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) is the most common chronic liver condition worldwide and a major contributor to cirrhosis and hepatocellular carcinoma (HCC). While metabolic triggers such as obesity and insulin resistance are key drivers of MASLD, growing evidence has identified defects in intracellular quality
Alessandra Cazzaniga +4 more
wiley +1 more source
Kupffer Cells and Hepatocytes: A Key Relation in the Context of Canine Leishmaniasis. [PDF]
Rodrigues A +5 more
europepmc +1 more source
ABSTRACT Background and Aims Subclassifications of steatotic liver disease (SLD) are intended to provide a clinically meaningful framework for management. However, steatosis, cardiometabolic comorbidities and alcohol consumption are known to change over time.
Carmela Rapino +7 more
wiley +1 more source
[Role of Kupffer cells in liver regeneration with metabolic associated fatty liver disease in mice]. [PDF]
Wang TW +7 more
europepmc +1 more source
SETDB1 is progressively downregulated in ALD, correlating with disease severity. SETDB1 deficiency impairs LAP by disrupting Rubicon membrane localization, leading to defective lipid droplet clearance. Concurrently, loss of SETDB1 reduces nuclear LC3B, causing R‐loop accumulation and cGAS‐STING‐driven inflammation. Lipidated LC3B mediates LAP‐dependent
Yi Zhang +17 more
wiley +1 more source

